Anuncia Medical, Inc. news
Anuncia Medical Inc. (“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems, is pleased to announce the successful first implant of the Company’s FDA-cleared ReFlow™ Mini Flusher device in tandem with a “sonolucent” cranial plate (Clearfit® Cover, Longeviti, Baltimore MD) to allow noninvasive visualization of the implant functioning inside the fl
Even before Zachary was born nearly 11 years ago, his parents Sherry and Jason knew that he was going to be a special boy – and a wonderful sibling to a twin sister! Zachary was born with spina bifida and hydrocephalus, both of which were diagnosed while in utero.
As with many children in the hydrocephalus community, most parents have never heard of the condition, nor understand how it could impact their child’s life, as well as impact their own emotional health with conce
Surgeons at Intermountain Primary Children’s Hospital are the first in the nation to successfully implant a new brain shunt accessory for young patients with hydrocephalus, a neurological condition that causes a buildup of cerebrospinal fluid in the deep cavities of the brain that often causes frequent hospitalizations.
This extra fluid puts pressure on the brain and can cause brain damage. Hydrocephalus is characterized by head enlargement in infants. Treatment is often
Step 1: Locate
Locate the ReFlow Mini Flusher dome under the skin by touch. First, find the incision. Starting at the incision, trace toward the back of the head to find the flusher dome by touch.
The ReFlow Mini Flusher dome will be located closest to the ventricular catheter and incision site.
The valve is located after the flusher and should not be used for flushing.
Step 2: Press Down
Using your finger, press the center o
- Intermountain Primary Children’s Hospital First in the Country to Implant this Next Generation FDA-Cleared Device
- Company Welcomes Vice President of Sales & Marketing, Mark Geiger, Who Lives with Hydrocephalus
Anuncia Medical Inc. (“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems and neurocritical care, is pleased to announce